(Q43607272)

English

Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Evaluation of the influence of antacids and H2 antagonists on the absorption of moxifloxacin after oral administration of a 400mg dose to healthy volunteers (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1 reference

based on heuristic

inferred from title

author name string

H Stass

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

M F Böttcher

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

K Ochmann

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Clinical Pharmacokinetics

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

40 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

39-48

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Inhibition of enoxacin absorption by antacids or ranitidine

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200140001-00006

21 January 2018

Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200140001-00006

21 January 2018

Effect of sucralfate on pharmacokinetics of fleroxacin in healthy volunteers

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200140001-00006

21 January 2018

Sucralfate reduces the gastrointestinal absorption of norfloxacin

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200140001-00006

21 January 2018

Effect of antacid on absorption of the quinolone lomefloxacin

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200140001-00006

21 January 2018

Inhibition of norfloxacin absorption by antacids

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200140001-00006

21 January 2018

Effects of magnesium-aluminum hydroxide and calcium carbonate antacids on bioavailability of ofloxacin

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200140001-00006

21 January 2018

Effects of antacids, ferrous sulfate, and ranitidine on absorption of DR-3355 in humans

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200140001-00006

21 January 2018

Norfloxacin interaction with antacids and minerals

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200140001-00006

21 January 2018

Effect of an antacid containing magnesium and aluminum on absorption, metabolism, and mechanism of renal elimination of pefloxacin in humans

1 reference

https://api.crossref.org/works/10.2165%2F00003088-200140001-00006

21 January 2018

An integrated approach to the pharmacokinetic analysis of drug absorption.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11352441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamics of fluoroquinolones

1 reference

https://pubmed.ncbi.nlm.nih.gov/11352441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanistic investigation of the reduction in antimicrobial activity of ciprofloxacin by metal cations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11352441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of multiple staggered doses of calcium on the bioavailability of ciprofloxacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/11352441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Achieving an optimal outcome in the treatment of infections. The role of clinical pharmacokinetics and pharmacodynamics of antimicrobials

1 reference

https://pubmed.ncbi.nlm.nih.gov/11352441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of Maalox and omeprazole on the bioavailability of trovafloxacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/11352441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cations in the didanosine tablet reduce ciprofloxacin bioavailability.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11352441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of BAY 12-8039, a new 8-methoxyquinolone, in human body fluids by high-performance liquid chromatography with fluorescence detection using on-column focusing

1 reference

https://pubmed.ncbi.nlm.nih.gov/11352441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro activity of BAY 12-8039, a new 8-methoxyquinolone.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11352441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of aluminum and magnesium antacids and ranitidine on the absorption of ciprofloxacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/11352441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/11352441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of gastric acidity on enoxacin absorption

1 reference

https://pubmed.ncbi.nlm.nih.gov/11352441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complexes of Ciprofloxacin with Metal Ions Contained in Antacid Drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/11352441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fluoroquinolones: interaction profile during enteral absorption.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11352441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastrointestinal secretion of ciprofloxacin. Evaluation of the charcoal model for investigations in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/11352441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of chronic administration of calcium carbonate on the bioavailability of oral ciprofloxacin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11352441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of pharmacokinetic interaction as an equivalence problem

1 reference

https://pubmed.ncbi.nlm.nih.gov/11352441

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003088-200140001-00006

0 references

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43607272&oldid=2206156663"